首页> 美国卫生研究院文献>other >proPSA Measurements in Serum and Tissue are Associated with Treatment Necessity Among Men Enrolled in Expectant Management for Prostate Cancer

【2h】

proPSA Measurements in Serum and Tissue are Associated with Treatment Necessity Among Men Enrolled in Expectant Management for Prostate Cancer

机译：血清和组织中的ProPSA测量与参加前列腺癌预期管理的男性的治疗必然相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeWe assessed the association of quantitative clinical and pathologic information, including serum and tissue proPSA, with outcomes among men with prostate cancer (PCa) managed expectantly.

著录项

期刊名称 other
作者
Danil V. Makarov; Sumit Isharwal; Lori J. Sokoll; Patricia Landis; Cameron Marlow; Jonathan I. Epstein; Alan W. Partin; H. Ballentine Carter; Robert W. Veltri;
展开▼
作者单位

展开▼
年(卷),期 -1(15),23
年度 -1
页码 7316–7321
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
Prostate cancer expectant management proPSA serum benign-adjacent cancer unfavorable biopsy conversion prediction;

机译：前列腺癌;预期管理;proPSA;血清;良性相邻;癌症;活检转换不良;预测;

相似文献

外文文献
中文文献
专利

1. Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer. [J] . Makarov DV, Isharwal S, Sokoll L Clinical cancer research: an official journal of the American Association for Cancer Research . 2009,第23期

机译：血清和组织中前列腺特异性抗原的测量与参加前列腺癌预期治疗的男性的治疗必要性相关。
2. ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance program. [J] . Isharwal S, Makarov DV, Sokoll LJ, Urology . 2011,第3期

机译：ProPSA和诊断性活检组织DNA含量的组合提高了准确性，从而可以预测参加主动监测计划的男性中需要进行前列腺癌治疗的人数。
3. Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent. [J] . Makarov DV, Marlow C, Epstein JI, The Prostate . 2008,第2期

机译：使用核形态计量术预测低度，低度前列腺癌男性患者的治疗需求，该研究纳入了具有治愈意图的预期管理方案。
4. Instrument towards Faster Diagnosis and Treatment of Prostate Cancer - Resonance Sensor Stiffness Measurements on Human Prostate Tissue in vitro [C] . V. Jalkanen, B.M. Andersson, O.A. Lindahl World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：更快诊断和治疗前列腺癌的仪器-人体前列腺组织的共振传感器刚度测量
5. Use of Serum Prostate Specific Antigen Doubling Time and Change to Determine Need for Secondary Treatment for Prostate Cancer following Radical Prostatectomy [D] . Huang, Erica Jayee. 2021

机译：使用血清前列腺特异性抗原的倍增时间和变化，以确定自由基前列腺切除术后前列腺癌的继发性治疗
6. ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program [O] . Sumit Isharwal, Danil V. Makarov, Lori J. Sokoll, -1

机译：propsa和诊断活检组织DNa含量的组合提高了精度在主动监测计划以预测极品治疗前列腺癌是男性已登记
7. Editorial comment on: Measurement of serum isoform –2proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2–10 ng/ml [O] . Alberto Abrate, Alchiede Simonato 2017

机译：编辑评论：血清同种型的测量-2 ProCSA衍生物对患者诊断前列腺特异性抗原水平2-10 ng / ml的患者前列腺癌的磁共振成像进行了卓越的准确性

proPSA Measurements in Serum and Tissue are Associated with Treatment Necessity Among Men Enrolled in Expectant Management for Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅